Sadile Francesco, Bernasconi Alessio, Russo Sergio, Maffulli Nicola
Department of Public Health, Orthopaedic and Traumatology Unit, 'Federico II' Naples University School of Medicine and Surgery, Naples, Italy.
Department of Musculoskeletal Disorders, University of Salerno School of Medicine and Dentistry, Salerno, Italy Centre for Sports and Exercise Medicine, William Harvey Research Institute, Bart's and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK
Br Med Bull. 2016 Jun;118(1):33-49. doi: 10.1093/bmb/ldw010.
Osteonecrosis of femoral head (ONFH) leads to hip osteoarthritis (HOA); among joint preserving treatments (JPT), the role of core decompression (CD) is still debated. We assessed the efficacy of CD compared with all other JPT in delaying the natural osteonecrosis evolution to HOA.
Following the PRISMA checklist, the Medline and Scopus databases were searched. Fifteen- to 70-year-old subjects with ONFH with a minimum follow-up of 24 months were considered. The outcomes evaluated were patient clinical status, radiographic progression and total hip arthroplasty (THA) or further surgery (FS) need. Risk ratio (RR) was calculated for every outcome reported. RCT, CCT and prospective studies were included.
A total of 12 studies (776 patients) met the inclusion criteria. Clinical outcome (RR = 1.14; 95% CI 0.58-2.32; P = 0.05), radiographic progression (RR = 1.64; 95% CI 1.14-2.35; P = 0.05) and the need for THA/FS (RR = 1.52; 95% CI 0.95-2.45; P = 0.05) suggested a slight superiority of other JPT compared with CD.
High heterogeneity of the primary investigations was the main limitation of our study.
The efficacy and effectiveness of core decompression for ONFH are, at best, no better than other joint preserving strategies. The more recent scientific evidence seems to suggest that such procedure is less successful than other joint preserving strategies.
Further studies are needed to identify the best therapeutic approach to the ONFH.
股骨头坏死(ONFH)会导致髋骨关节炎(HOA);在保关节治疗(JPT)中,髓芯减压术(CD)的作用仍存在争议。我们评估了与所有其他保关节治疗相比,髓芯减压术在延缓股骨头坏死自然发展为髋骨关节炎方面的疗效。
按照PRISMA清单检索了Medline和Scopus数据库。纳入了年龄在15至70岁、患有股骨头坏死且随访时间至少为24个月的受试者。评估的结果包括患者临床状况、影像学进展以及全髋关节置换术(THA)或进一步手术(FS)的需求。计算了所报告的每个结果的风险比(RR)。纳入了随机对照试验(RCT)、队列对照试验(CCT)和前瞻性研究。
共有12项研究(776例患者)符合纳入标准。临床结果(RR = 1.14;95%置信区间0.58 - 2.32;P = 0.05)、影像学进展(RR = 1.64;95%置信区间1.14 - 2.35;P = 0.05)以及THA/FS的需求(RR = 1.52;95%置信区间0.95 - 2.45;P = 0.05)表明,与髓芯减压术相比,其他保关节治疗略具优势。
主要研究的高度异质性是我们研究的主要局限性。
对于股骨头坏死,髓芯减压术的疗效和有效性充其量并不优于其他保关节策略。最新的科学证据似乎表明,该手术不如其他保关节策略成功。
需要进一步研究以确定治疗股骨头坏死的最佳方法。